Morepen Laboratories Limited, a leading manufacturer of high-quality APIs, Home Diagnostics, Formulations and OTC products, has approved an incoming investment of Rs. 433 crore in the Extra-Ordinary General Meeting (EGM) of the company. The members approved the issue and allotment of 58.50 million equity shares for cash to Corinth Investment Holdings AG, Switzerland Rs.41.60 per…
Tag: Andreas Matsas
Morepen Group seals $100mn investment from Corinth Group of Switzerland
by
•The Board of Directors of Morepen Laboratories Limited approved the investment proposed by Corinth Group (Corinth), a global private investment Group headquartered in Switzerland, ‘to the extent of USD 32.50 million in the parent company, Morepen Laboratories Limited (“Morepen” or “The Company”), out of a total USD 100 million investment in the promoter group, subject…